This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Actelion Pharmaceuticals Ltd. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Stéphanie Combes: Innovator in Pharmaceutical Chemistry
Introduction
Stéphanie Combes is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds that serve as medicaments.
Latest Patents
Stéphanie Combes holds a patent for "Salts of isobutyric acid (1R*, 2R*, 4R*)-2-(2-{[3-(4,7-dimethoxy-1H-benzoimidazol-2-yl)-methyl-amino}-ethyl)-5-phenyl-bicyclo[2.2.2]oct-5-en-2-yl ester." This invention relates to crystalline salts of isobutyric acid and includes processes for their preparation, pharmaceutical compositions containing these salts, and their use as medicaments, especially as calcium channel blockers. He has 1 patent to his name.
Career Highlights
Stéphanie Combes is currently associated with Actelion Pharmaceuticals Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating new therapeutic options for patients.
Collaborations
Throughout his career, Stéphanie has collaborated with esteemed colleagues such as Stefan Abele and Jacques-Alexis Funel. These partnerships have fostered innovation and contributed to the success of various projects.
Conclusion
Stéphanie Combes exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile